Can doxycycline effectively treat both gonorrhea and chlamydia?

Doxycycline for Treatment of Gonorrhea and Chlamydia

Doxycycline is the recommended first-line treatment for chlamydia but is NOT a recommended treatment for gonorrhea due to widespread antimicrobial resistance, though it remains effective against many N. gonorrhoeae strains. For active gonorrhea infection, you must use ceftriaxone 500 mg IM as the primary treatment 1.

Treatment Recommendations by Infection

For Chlamydia (Any Site)

• Doxycycline 100 mg orally twice daily for 7 days is the preferred treatment 2, 3
• This applies to urethral, endocervical, rectal, and other chlamydial infections
• Doxycycline has demonstrated superior efficacy compared to azithromycin, particularly for rectal chlamydia, with cure rates of 92-100% versus 74-87% for azithromycin 4
• A recent controlled study showed doxycycline achieved 26% higher microbiological cure than azithromycin for rectal infections 4
• Implementation of doxycycline-first protocols has resulted in significant reductions in recurrent/persistent chlamydia infections 5

For Gonorrhea (Active Infection)

• Ceftriaxone 500 mg IM single dose is the required treatment 1
• Doxycycline is explicitly NOT recommended as primary gonorrhea treatment due to elevated antimicrobial resistance 2
• If chlamydial coinfection has not been excluded, add doxycycline 100 mg orally twice daily for 7 days to the ceftriaxone 1

Historical Context Worth Noting

Older guidelines from 2010 listed doxycycline as an alternative for uncomplicated gonorrhea 6, and a 1981 study showed a 3-day high-dose doxycycline regimen (300 mg daily) achieved 98% cure rates 7. However, this is outdated—resistance patterns have changed dramatically, making doxycycline unreliable as monotherapy for gonorrhea today 2.

Key Clinical Distinctions

Treatment vs. Prevention

The evidence you may have encountered about doxycycline and gonorrhea likely refers to postexposure prophylaxis (PEP), not treatment of active infection:

• Doxy-PEP (200 mg within 72 hours after sex) reduces gonorrhea acquisition by approximately 57% in MSM and transgender women 8
• This prophylactic effect does NOT translate to treating established gonorrhea infections
• The 2024 CDC guidelines recommend doxy-PEP for prevention in high-risk MSM/transgender women with recent bacterial STIs, but this is a separate indication from treatment 2

Practical Algorithm for Urethritis/Cervicitis

When you have confirmed testing:

• Chlamydia only → Doxycycline 100 mg BID × 7 days
• Gonorrhea only → Ceftriaxone 500 mg IM once
• Both infections → Ceftriaxone 500 mg IM once PLUS doxycycline 100 mg BID × 7 days
• Neither confirmed but high suspicion → Treat empirically for both with the combination above

When testing is pending or unavailable:

• Treat empirically with ceftriaxone 500 mg IM PLUS doxycycline 100 mg BID × 7 days to cover both pathogens 1, 9

Critical Pitfalls to Avoid

1. Do not use doxycycline alone for suspected or confirmed gonorrhea—resistance rates make this inadequate therapy that risks treatment failure and ongoing transmission 2

2. Do not confuse doxy-PEP (prevention) with treatment protocols—the 200 mg post-sex dosing is for prophylaxis in uninfected individuals, not for treating active infections 2

3. Do not substitute azithromycin for doxycycline when treating chlamydia—doxycycline is now preferred due to superior efficacy, particularly for rectal infections 4, 5

4. Ensure proper dosing duration—the full 7-day course of doxycycline is necessary for chlamydia treatment; shorter courses are inadequate 3

Administration Considerations

• Take doxycycline with food or milk to minimize gastrointestinal side effects 3
• Advise patients about photosensitivity risk 2
• Instruct sexual abstinence until completion of therapy and partner treatment 6
• Retest 3 months after treatment, as reinfection rates are high 2